Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Guardion Health Sciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 12 | 1 | 15 | +4 |
| Shares | 67.3K | 10.0K | 106.1K | +48.9K (+85.4%) |
| Value | $674.9K | $100.7K | $587.7K | +$13.4K (+2.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Guardion Health Sciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 12,609 | $69.9K | 0.00% |
| HRT Financial LP | 11,579 | $64.0K | 0.00% |
| BlackRock, Inc. | 10,030 | $55.6K | 0.00% |
| TD Waterhouse Canada Inc. | 1 | $3 | 0.00% |
Sold out (0)
Institutions that held Guardion Health Sciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
None.
Not filed for Q3 2024 yet (1)
Institutions that held Guardion Health Sciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 10,030 | $100.7K |